Anne Layne-Farrar is speaking at this conference on “Evolving Antitrust IP Guidelines across Asia – What’s ahead for technology and pharma?”.
For more information on this conference, click here.
Assessing umbrella pricing incentives
When collusive agreements involve a subset of firms in an industry, they may create the incentive and ability for firms that are not participants in the cartel...